These data are in line with another study, which proved that, over a 16-week follow up, moderate PA efficiency resulted in reductions in liver steatosis, weight, BMI, levels of fasting glucose and ALT and LDL-C in the plasma. This evidence concerns the gene GPT and Hepatic steatosis.